Mobile Health Intervention to Close the Guidelines-To-Practice Gap in Hypertension Treatment: Protocol for the mGlide Randomized Controlled Trial.

Mobile Health Intervention to Close the Guidelines-To-Practice Gap in Hypertension Treatment: Protocol for the mGlide Randomized Controlled Trial.
复制标题

移动健康干预缩小高血压治疗指南与实践的差距:mGlide随机对照试验方案。

DOI:
10.2196/25424
复制
发表时间:
2021-01-25
影响因子:
1.7
通讯作者:
Everson-Rose SA
Everson-Rose SA
中科院分区:
其他
文献类型:
--
作者:
Lakshminarayan K;Murray TA;Westberg SM;Connett J;Overton V;Nyman JA;Culhane-Pera KA;Pergament SL;Drawz P;Vollbrecht E;Xiong T;Everson-Rose SA

文献摘要

参考文献

被引文献

相似文献

高血压治疗不理想仍然是一个普遍存在的问题,特别是在少数民族和社会经济弱势群体中。我们提出了一个基于卫生系统的干预与不同的患者群体使用现成的智能手机技术。这一干预措施旨在增强患者的权能,并在患者及其医疗团队之间建立伙伴关系,以促进高血压控制。mGlide随机对照试验是美国国立卫生研究院资助的一项研究,旨在评估基于移动医疗(mHealth)的干预(跨专业医疗团队和患者之间的积极合作伙伴关系)是否比临床状态护理比较能产生更好的高血压控制率。我们正在招募450名参与者,包括来自不同卫生系统的中风幸存者和心血管疾病风险较高的初级保健患者。这些系统包括急性中风服务(n=100),学术医疗中心(n=150)和社区医疗中心,包括为低收入和少数民族(拉丁裔,苗族,非洲裔美国人,索马里人)患者服务的联邦合格医疗中心(n=200)。主要目的是测试6个月移动健康干预与标准护理的临床效果。次要目的评估12个月的持续高血压控制率;描述供应商对系统可用性和满意度的体验;检查患者经历,包括药物依从性和药物使用自我效能,自我评估的健康和生活质量,以及不良事件发生率;并完成成本效益分析。到目前为止,我们随机选取了107名参与者(54名干预组,53名对照组)。本研究将提供证据,证明在为不同患者群体服务的卫生系统中,一个现成的移动医疗模式是否比临床状态护理更好地弥合了高血压治疗的指南与实践差距。Clinicaltrials.gov NCT03612271;https://clinicaltrials.gov/ct2/show/NCT03612271 derr1 - 10.2196/25424
Suboptimal treatment of hypertension remains a widespread problem, particularly among minorities and socioeconomically disadvantaged groups. We present a health system–based intervention with diverse patient populations using readily available smartphone technology. This intervention is designed to empower patients and create partnerships between patients and their provider team to promote hypertension control. The mGlide randomized controlled trial is a National Institutes of Health–funded study, evaluating whether a mobile health (mHealth)-based intervention that is an active partnership between interprofessional health care teams and patients results in better hypertension control rates than a state-of-clinical care comparison. We are recruiting 450 participants including stroke survivors and primary care patients with elevated cardiovascular disease risk from diverse health systems. These systems include an acute stroke service (n=100), an academic medical center (n=150), and community medical centers including Federally Qualified Health Centers serving low-income and minority (Latino, Hmong, African American, Somali) patients (n=200). The primary aim tests the clinical effectiveness of the 6-month mHealth intervention versus standard of care. Secondary aims evaluate sustained hypertension control rates at 12 months; describe provider experiences of system usability and satisfaction; examine patient experiences, including medication adherence and medication use self-efficacy, self-rated health and quality of life, and adverse event rates; and complete a cost-effectiveness analysis. To date, we have randomized 107 participants (54 intervention, 53 control). This study will provide evidence for whether a readily available mHealth care model is better than state-of-clinical care for bridging the guideline-to-practice gap in hypertension treatment in health systems serving diverse patient populations. Clinicaltrials.gov NCT03612271; https://clinicaltrials.gov/ct2/show/NCT03612271 DERR1-10.2196/25424
DOI: 10.1161/str.0000000000000046
发表时间: 2014-12
期刊: Stroke
影响因子: 8.3
作者:
Meschia JF;Bushnell C;Boden-Albala B;Braun LT;Bravata DM;Chaturvedi S;Creager MA;Eckel RH;Elkind MS;Fornage M;Goldstein LB;Greenberg SM;Horvath SE;Iadecola C;Jauch EC;Moore WS;Wilson JA;American Heart Association Stroke Council;Council on Cardiovascular and Stroke Nursing;Council on Clinical Cardiology;Council on Functional Genomics and Translational Biology;Council on Hypertension
通讯作者: Council on Hypertension
DOI: 10.1183/13993003.00547-2020
发表时间: 2020-05-01
影响因子: 24.3
作者:
Guan, Wei-jie;Liang, Wen-hua;He, Jian-xing
通讯作者: He, Jian-xing
DOI: 10.1161/strokeaha.110.606764
发表时间: 2011-08-01
期刊: STROKE
影响因子: 8.3
作者:
Arima, Hisatomi;Anderson, Craig;Chalmers, John
通讯作者: Chalmers, John
DOI: 10.1016/j.amjcard.2011.09.051
发表时间: 2012-02-15
影响因子: 2.8
作者:
Gee, Marianne E.;Bienek, Asako;Nolan, Robert P.
通讯作者: Nolan, Robert P.
DOI: 10.1001/jama.2020.6775
发表时间: 2020-01-01
期刊: JAMA, Journal of the American Medical Association
影响因子: --
作者:
Richardson, Safiya;Hirsch, Jamie S.;,
通讯作者: ,